WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Stereo Investigator
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sher, E.
Right arrow Articles by Carbone, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sher, E.
Right arrow Articles by Carbone, E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*POTASSIUM CHLORIDE
*TRITIUM

 Previous Article  |  Next Article 

Volume 16, Number 11, Issue of June 1, 1996 pp. 3672-3684
Copyright ©1996 Society for Neuroscience

Activation of delta -Opioid Receptors Inhibits Neuronal-Like Calcium Channels and Distal Steps of Ca2+-Dependent Secretion in Human Small-Cell Lung Carcinoma Cells

Received Dec. 28, 1995; revised March 18, 1996; accepted March 20, 1996.

E. Sher1, P. Cesare2, A. Codignola1, F. Clementi1, P. Tarroni3, A. Pollo2, V. Magnelli2, and E. Carbone2

1 CNR Center of Cellular and Molecular Pharmacology, Department of Medical Pharmacology, University of Milan, Milan, Italy, 2 Department of Neuroscience, University of Turin, Turin, Italy, and 3 Bayer Pharmaceutical Division Research, San Raffaele International Biomedical Science Park, Milan, Italy

Human small-cell lung carcinoma (SCLC) cells express neuronal-like voltage-operated calcium channels (VOCCs) and release mitogenic hormones such as serotonin (5-HT). Opioid peptides, on the other hand, have been shown to reduce SCLC cell proliferation by an effective autocrine pathway.

Here we show that in GLC8 SCLC cells, only delta -opioid receptor subtype mRNA is expressed. Consistently, the selective delta -opioid agonist [D-Pen2-Pen5]-enkephalin (DPDPE), but not µ and kappa  agonists, potently and dose-dependently inhibits high-threshold (HVA) VOCCs in these cells. As in peripheral neurons, this modulation is largely voltage-dependent, mediated by pertussis toxin (PTX)-sensitive G-proteins, cAMP-independent, and mainly affecting N-type VOCCs.

With the same potency and selectivity, DPDPE also antagonizes the Ca2+-dependent release of [3H]serotonin ([3H]5-HT) from GLC8 cells. However, DPDPE inhibits not only the depolarization-induced release, but also the Ca2+-dependent secretion induced by thapsigargin or ionomycin. This suggests that besides inhibiting HVA VOCCs, opioids also exert a direct depressive action on the secretory apparatus in GLC8 cells. This latter effect also is mediated by a PTX-sensitive G-protein but, contrary to VOCC inhibition, it can be reversed by elevations of cAMP levels.

These results show for the first time that opioids effectively depress both Ca2+ influx and Ca2+-dependent hormone release in SCLC cells by using multiple modulatory pathways. It can be speculated that the two mechanisms may contribute to the opioid antimitogenic action on lung neuroendocrine carcinoma cells.

Key words: small-cell lung carcinoma; human; voltage-operated calcium channels; hormone secretion; opioid modulation; G-proteins




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
R. M. Quock, T. H. Burkey, E. Varga, Y. Hosohata, K. Hosohata, S. M. Cowell, C. A. Slate, F. J. Ehlert, W. R. Roeske, and H. I. Yamamura
The delta -Opioid Receptor: Molecular Pharmacology, Signal Transduction, and the Determination of Drug Efficacy
Pharmacol. Rev., September 1, 1999; 51(3): 503 - 532.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. L. Svingos, C. L. Clarke, and V. M. Pickel
Cellular Sites for Activation of delta -Opioid Receptors in the Rat Nucleus Accumbens Shell: Relationship with Met5-Enkephalin
J. Neurosci., March 1, 1998; 18(5): 1923 - 1933.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. I. Rusin, D. R. Giovannucci, E. L. Stuenkel, and H. C. Moises
kappa -Opioid Receptor Activation Modulates Ca2+ Currents and Secretion in Isolated Neuroendocrine Nerve Terminals
J. Neurosci., September 1, 1997; 17(17): 6565 - 6574.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D.-S. Koh and B. Hille
Modulation by neurotransmitters of catecholamine secretion from sympathetic ganglion neurons detected by amperometry
PNAS, February 18, 1997; 94(4): 1506 - 1511.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-